US Patent Issued to Kronos Bio on April 1 for "Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-apyrazin-8-amine as a Syk inhibitor" (Washington, Maryland, California, Connecticut Inventors)

Posted On: 2025-04-02

ALEXANDRIA, Va., April 2 -- United States Patent no. 12,263,163, issued on April 1, was assigned to Kronos Bio Inc. (San Mateo, Calif.).

"Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-apyrazin-8-amine as a Syk inhibitor" was invented by Peter A. Blomgren (Issaquah, Wash.), Kevin S. Currie (North Bend, Wash.), Jeffrey E. Kropf (Issaquah, Wash.), Seung H. Lee (Sammamish, Wash.), Jennifer R. Lo (Seattle), Scott A. Mitchell (Kenmore, Wash.), Aaron C. Schmitt (Hamden, Conn.), Jin-Ming Xiong (Bel Air, Md.), Jianjun Xu (Bellevue, Wash.), Sundaramoorthi Swaminathan (Burlingame, Calif.) and Zhongdong Zhao (Bellevue, Wash.).

According to the abstract* released by the U.S. Patent & Trade...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

US Patent Issued to Kronos Bio on April 1 for "Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-n-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-apyrazin-8-amine as a Syk inhibitor" (Washington, Maryland, California, Connecticut Inventors)